Back to Authors

Lin, Yi

https://orcid.org/0000-0003-0282-2414

A5016610534 | I1330342723

Mayo Clinic

Citations 32

Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3158-3161

10.1182/blood-2022-158248

P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 861-862

10.1097/01.hs9.0000846752.50612.48